These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20495160)

  • 1. Comorbidity of ADHD and Substance Use Disorder (SUD): a neuroimaging perspective.
    Frodl T
    J Atten Disord; 2010 Sep; 14(2):109-20. PubMed ID: 20495160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
    van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
    Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurobiology of attention deficit/hyperactivity disorder].
    Purper-Ouakil D; Lepagnol-Bestel AM; Grosbellet E; Gorwood P; Simonneau M
    Med Sci (Paris); 2010 May; 26(5):487-96. PubMed ID: 20510147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
    Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
    Upadhyaya HP
    J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition.
    Martinez-Raga J; Szerman N; Knecht C; de Alvaro R
    Int J Adolesc Med Health; 2013; 25(3):231-43. PubMed ID: 23846135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective.
    Babcock T; Ornstein CS
    Postgrad Med; 2009 May; 121(3):73-82. PubMed ID: 19491543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues.
    Wilens TE
    Psychiatr Clin North Am; 2004 Jun; 27(2):283-301. PubMed ID: 15063998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autism and ADHD: how far have we come in the comorbidity debate?
    Gargaro BA; Rinehart NJ; Bradshaw JL; Tonge BJ; Sheppard DM
    Neurosci Biobehav Rev; 2011 Apr; 35(5):1081-8. PubMed ID: 21093480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders.
    Sizoo B; van den Brink W; Gorissen van Eenige M; van der Gaag RJ
    J Nerv Ment Dis; 2009 Jun; 197(6):450-4. PubMed ID: 19525746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.
    Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J
    J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.
    Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K
    Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADHD and comorbidity in childhood.
    Spencer TJ
    J Clin Psychiatry; 2006; 67 Suppl 8():27-31. PubMed ID: 16961427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E; Gastpar M
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders.
    Levin FR
    J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional brain imaging in adult attention-deficit/hyperactivity disorder.
    Cubillo A; Rubia K
    Expert Rev Neurother; 2010 Apr; 10(4):603-20. PubMed ID: 20367211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity of alcohol and substance dependence with attention-deficit/hyperactivity disorder (ADHD).
    Ohlmeier MD; Peters K; Te Wildt BT; Zedler M; Ziegenbein M; Wiese B; Emrich HM; Schneider U
    Alcohol Alcohol; 2008; 43(3):300-4. PubMed ID: 18326548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The consequences of attention-deficit/hyperactivity disorder in adults.
    Goodman DW
    J Psychiatr Pract; 2007 Sep; 13(5):318-27. PubMed ID: 17890980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD.
    Torgersen T; Gjervan B; Rasmussen K; Vaaler A; Nordahl HM
    Atten Defic Hyperact Disord; 2013 Mar; 5(1):59-67. PubMed ID: 23104523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.